Skip to content
No results
IngenOx
  • Home
  • About
    • Executive Team
    • Board of Directors
    • Strategic Collaborations
    • Careers
  • Products
    • Zabadinostat (CXD101)
    • PRMT5 Inhibitor (AT101)
    • Cancer Vaccine (PCV001)
  • Press Releases
  • Pipeline
  • Publications
  • Contact
IngenOx
  • Home
  • About
    • Executive Team
    • Board of Directors
    • Strategic Collaborations
    • Careers
  • Products
    • Zabadinostat (CXD101)
    • PRMT5 Inhibitor (AT101)
    • Cancer Vaccine (PCV001)
  • Press Releases
  • Pipeline
  • Publications
  • Contact
IngenOx

Publications

Zabadinostat

CXD101 Phase I Study Results

Eyre, 2018

CXD101 Phase 2a Cohort Expansion

Booth, 2021

Immune modulation underpins the anti-cancer activity of HDAC inhibitors

Blaszczak, 2021

CXD101 MSS CRC Phase 2 Study (CAROSELL) Results

Saunders, 2022

The HDAC inhibitor zabadinostat is a systemic regulator of adaptive immunity

Liu, 2023

AT-101 (PRMT5)

PRMT5 promotes cancer cell migration and invasion through the E2F pathway

Barczak 2020

Arginine methylation regulates the p53 response

Jansson, 2008

Arginine methylation controls growth regulation by E2F-1

Cho, 2012

Arginine Methylation-Dependent Reader-Writer Interplay Governs Growth Control by E2F-1

Zheng, 2013

Arginine methylation expands the regulatory mechanisms and extends the genomic landscape under E2F control

Roworth, 2019

Combination of PRMT5 inhibitor with Vactosertib

Hong, 2023

PCV (cancer vaccine)

LncRNA-derived peptides are immunogenic and drive a potent antitumour response

Barczak, 2023

IngenOx

  • Registered Address: Magdalen Centre Oxford Science Park Robert Robinson Avenue Oxford, OX4 4GA
  • Email: enquiries@ingenOx.com

Products

  • Zabadinostat (CXD101)
  • PRMT5 Inhibitor (AT101)
  • Cancer Vaccine (PCV001)
  • Pipeline

About Us

  • About
  • Executive Team
  • Board of Directors
  • Strategic Collaborations

Useful Links

  • Careers
  • Press Releases
  • Publications
  • Contact

Copyright © 2025 

  • Anti-Slavery Statement
  • Privacy Statement